Since commercial development in 2003, the usage of modern electronic cigarette (e-cigarette) continues to increase amongst people who have never smoked, ex-smokers who have switched to e-cigarettes, and dual-users of both conventional cigarettes and e-cigarettes. With such an increase in use, knowledge of the irritative, toxic and potential carcinogenic effects on the lungs is increasing. This review article will discuss the background of e-cigarettes, vaping devices and explore their popularity. We will further summarise the available literature describing the mechanism of lung injury caused by e-cigarette or vaping use.
Exosomes, a class of extra cellular nano-sized vesicles (EVs), and their contents have gained attention as potential sources of information on tumor detection and regulatory drivers of tumor progression and metastasis. The effect of exosomes isolated from patients with an Epidermal Growth Factor Receptor (EGFR)-mutated adenocarcinoma on the promotion of epithelial–mesenchymal transition (EMT) and invasion were examined. Exosomes derived from serum of patients with EGFR-mutated non-small cell lung cancer (NSCLC) mediate the activation of the Phosphoinositide 3-kinase (PI3K)/AKT/ mammalian target of rapamycin (mTOR) pathway and induce an invasion through the up-regulation of matrix metalloproteinase-9 (MMP-9) in A549 cells. We observed a significant increase in the expression of vimentin, a mesenchymal marker, while retaining the epithelial characteristics, as evidenced by the unaltered levels of E-cadherin and Epithelial cell adhesion molecule (EPCAM). We also observed an increase of nuclear factor erythroid 2-related factor 2 (NFR2) and P-cadherin expression, markers of hybrid EMT. Exosomes derived from EGFR-mutated adenocarcinoma serum could be a potential mediator of hybrid EMT and tumor invasion. Understanding how cancerous cells communicate and interact with their environment via exosomes will improve our understanding of lung cancer progression and metastasis formation.
This case describes a woman in her 20s with a 6-month history of progressive exertional dyspnoea and cough. Examination revealed hypoxia on room air, sinus tachycardia, finger clubbing and bibasal inspiratory crackles. Inflammatory markers were mildly elevated and empirical antimicrobial therapy was commenced. A multidisciplinary discussion consensus diagnosis of acute interstitial pneumonitis was made based on the findings of high-resolution CT of the chest, macrophage predominant bronchoalveolar lavage cell differential and surgical lung biopsy. There was clinical and radiological deterioration despite glucocorticoids and antifibrotic therapy. A body mass index of 37.5 kg/m2 precluded her from lung transplant assessment and consideration. Following consultation with the weight management service, she was commenced on glucagon-like peptide 1 (GLP-1) analogue therapy. She had a remarkable response within 6 months, was listed for lung transplantation, and within 18 months of her initial presentation, a double lung transplantation was performed.
This case describes a woman in her 50s who presented with recurrent lower respiratory tract infections. She was an ex-smoker and had worked on a livestock farm for many years. Chest radiograph and CT of the chest revealed multiple bilateral pulmonary nodules. Bronchoalveolar lavage and transbronchial biopsy did not confirm a unifying diagnosis and thus, surgical biopsy was pursued. Video-assisted thoracoscopic surgical guided biopsy of the right upper, middle and lower lobes demonstrated intraparenchymal minute nodules, consisting of bland epithelioid cells without any evidence of malignancy. The nodules stained positive for neural cell adhesion molecule (CD56) and progesterone receptor with weakly positive epithelial membrane antigen and smooth muscle actin. The combination of this characteristic staining pattern, the diffuse subcentimetre nature of the nodules and this clinical presentation fit with a diagnosis of the ultra-rare pulmonary disease, diffuse pulmonary meningotheliomatosis (DPM). This case highlights a rare cause of bilateral diffuse pulmonary nodules and thus, the breadth of differential diagnoses that need to be considered when approaching such a finding. Careful history-taking and thorough workup is often needed, typically requiring input from multiple specialties. DPM, while rare, should not be overlooked when considering the underlying cause of this presentation, especially in female patients. This case reiterates how common clinical presentations can unveil rare conditions and the contributions of physicians, pathologists and radiologists in the diagnosis and management of these complex diseases.
Aims and objectives: Cellular lipids and lipid mediators play roles in inflammation and the development and resolution of ER stress. Lipid homeostasis is important in the lung as lipid makes up 90% of surfactant. We hypothesise that aberrant lipid metabolism and the consequences on lipid mediators contributes to the pro-fibrotic niche in IPF. Methods: Lung tissue from IPF and control patients were analysed for targeted quantitative measurement of >1,100 lipids. Primary human fibroblasts were exposed to lipids identified as increased on IPF tissue lipidomic analysis. Impact on proliferation genes and proteins, and ER stress genes was measured. Results: There was an increase in pulmonary lipid content from patients with IPF compared to control (23.16nmol/mg vs. 18.66nmol/mg, p=0.0317). Specific increases were noted in 16:0 and 20:4 containing lipids. ACTA2 and Col1a1 expression were upregulated in fibroblasts following exposure to saturated phosphatidylcholine 16:0 (PC 16:0) (p<0.001) and downregulated after unsaturated PC 20:4 (p<0.01). Oxidized PC 20:4,16:0 in contrast resulted in upregulation of ACTA2 and Col1a1 expression (p<0.01), and genetic markers of ER Stress (XBP1, DDIT3, HSPA5)(P<0.05). IPF fibroblasts are protected against the pro-fibrotic impact of TGFb (P<0.001) when primed with PC 20:4 but not saturated or oxidized species. Conclusions: Abnormal lipid deposition is seen in IPF on lipidomic analysis. Saturated and oxidized lipids cause increased ER stress and production of pro-fibrotic cytokines, whereas unsaturated lipid results in decreased availability of these lipids for the generation of inflammatory and resolving lipid mediators preventing the normal reparative inflammatory process.
Introduction: There is increasing interest in the role of lipids in processes that modulate fibrosis. Specifically, some inherited surfactant dysfunction disorders result in pulmonary fibrosis. Surfactant consists of phospholipids and smaller quantities of neutral lipids such as cholesterol ester (CE). Tissue lipidomics on mouse bleomycin models demonstrates increased total lipid compared to control. Aims & objectives: To perform lipidomic analysis on human IPF lung tissue and assess the impact of specific lipids on human fibroblasts. Methods: Lung tissue from human IPF and control patients (n=10) were analysed for targeted quantitative measurement of >1,100 lipid species. Primary cell culture of human IPF and control fibroblasts was performed and cells were exposed to lipid species identified as increased on IPF tissue lipidomic analysis. Expression of alpha-smooth muscle actin (aSMA) and collagen 1 (Col1a1) were measured to assess for myofibroblast-like transition following lipid exposure. Results: There was an increase in pulmonary lipid content in patients with IPF compared to control (23.16nmol/mg vs. 18.66nmol/mg, p=0.0317). Specific increases were noted in 16:0, 20:4, and 22:6-containing lipids within both CE and PC species. Dose-related increases in aSMA and Col1a1 protein and RNA expression occur in human fibroblasts exposed to PC-16.0 and decreased expression when exposed to PC-20.4, CE 16.0, and CE 20.4. Conclusions: Abnormal lipid deposition is seen in IPF on lipidomic analysis. Specific lipid subgroups appear to impact fibroblast biology as seen by changes in aSMA and Col1a1 expression. Further investigation is still warranted to identify the specific action of lipids in fibrosis.